As of December 2024, SymBio Pharmaceuticals has a market cap of $55.29M. This makes SymBio Pharmaceuticals the world's 23241th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $49.00M | -24.29% |
2023 | $64.73M | -61.59% |
2022 | $168.50M | -43.84% |
2021 | $300.05M | 202.11% |
2020 | $99.32M | -37.56% |
2019 | $159.06M | -20.13% |
2018 | $199.16M | -13.24% |
2017 | $229.55M | -10.25% |
2016 | $255.76M | 5.17% |
2015 | $243.18M | -35.01% |
2014 | $374.21M | -6.05% |
2013 | $398.31M | 26.67% |
2012 | $314.46M | -37.24% |
2011 | $501.04M | - |